Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Mini Oral session

Invited discussant of abstracts 8MO, 37MO and 38MO


02 Mar 2021


Mini Oral session


Susan Galbraith


S.M. Galbraith

Author affiliations

  • Oncology R&d Department, Research & Early Development Dpt., AstraZeneca - IMED Biotech, CB4 0WG - Cambridge/GB


Login to access the resources on OncologyPRO.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings